{
  "id": "NGN_SA_B300381771345545036",
  "seed": "BATCH-300-38-1771345545036",
  "itemType": "standalone",
  "cognitiveSkill": "Generate Solutions",
  "questionType": "selectAll",
  "caseTitle": "Management of Myxedema Coma in the ED",
  "stem": "The nurse in the emergency department is caring for a 68-year-old female client brought in by family for profound lethargy. The client has a history of hypothyroidism and ran out of levothyroxine two weeks ago. Assessment findings include unresponsiveness to verbal stimuli, rectal temperature of 94.8째F (34.9째C), heart rate of 48/min, respiratory rate of 10/min and shallow, and blood pressure of 88/50 mmHg. The provider diagnoses the client with myxedema coma. Which interventions should the nurse anticipate and prepare to implement? Select all that apply.",
  "options": [
    {
      "id": "opt_3",
      "isCorrect": false,
      "optionText": "Administer a rapid 1-liter bolus of 0.9% sodium chloride."
    },
    {
      "id": "opt_7",
      "isCorrect": false,
      "optionText": "Administer a beta-blocker to manage cardiovascular strain."
    },
    {
      "id": "opt_1",
      "isCorrect": true,
      "optionText": "Administer IV levothyroxine as prescribed."
    },
    {
      "id": "opt_6",
      "isCorrect": true,
      "optionText": "Administer IV hydrocortisone as prescribed."
    },
    {
      "id": "opt_4",
      "isCorrect": true,
      "optionText": "Prepare for endotracheal intubation and mechanical ventilation."
    },
    {
      "id": "opt_5",
      "isCorrect": false,
      "optionText": "Administer a sedative to prevent agitation upon arousal."
    },
    {
      "id": "opt_2",
      "isCorrect": true,
      "optionText": "Initiate passive rewarming with warm blankets."
    }
  ],
  "answerBreakdown": {
    "correct": [
      "opt_1",
      "opt_2",
      "opt_4",
      "opt_6"
    ],
    "rationales": {
      "opt_1": {
        "point": "Administer IV levothyroxine as prescribed.",
        "explanation": "Levothyroxine is a synthetic form of thyroxine (T4), a thyroid hormone. In myxedema coma, the body's thyroid hormone levels are critically low, leading to a severe metabolic slowdown. IV administration is essential due to impaired gastrointestinal absorption in this condition. Levothyroxine increases metabolic rate, oxygen consumption, and body temperature. It also improves cardiac function by increasing the number and sensitivity of beta-adrenergic receptors in the heart. The dosage is carefully titrated to avoid cardiac stress. Monitor for signs of hyperthyroidism (e.g., tachycardia, arrhythmias) during treatment. Clinical Pearl: Start low and go slow with levothyroxine dosing, especially in elderly clients or those with cardiac disease.",
        "pathophysiology": "Myxedema coma represents the extreme manifestation of hypothyroidism, characterized by a profound deficiency of thyroid hormones (T3 and T4). This deficiency leads to a global decrease in metabolic activity, affecting virtually all organ systems. The reduced metabolic rate results in decreased thermogenesis, leading to hypothermia; decreased cardiac output and contractility, leading to bradycardia and hypotension; and slowed neurological function, leading to altered mental status and coma. The lack of thyroid hormone also impairs the body's ability to respond to stress, increasing the risk of adrenal insufficiency. IV levothyroxine directly addresses the hormone deficiency, initiating a cascade of metabolic and physiological improvements."
      },
      "opt_2": {
        "point": "Initiate passive rewarming with warm blankets.",
        "explanation": "Hypothermia is a significant concern in myxedema coma due to decreased metabolic rate and impaired thermoregulation. Passive rewarming involves using external measures like warm blankets to prevent further heat loss and allow the body to gradually raise its temperature. Active rewarming methods (e.g., heating pads, forced-air warmers) are contraindicated because they can cause rapid peripheral vasodilation, leading to a dangerous drop in blood pressure and potential cardiovascular collapse. Monitor the client's temperature closely and avoid rapid warming. Clinical Pearl: Avoid active rewarming in myxedema coma due to the risk of precipitating hypotension and arrhythmias.",
        "pathophysiology": "Hypothermia in myxedema coma results from the reduced metabolic rate caused by thyroid hormone deficiency. Thyroid hormones play a crucial role in regulating thermogenesis, the process by which the body generates heat. The deficiency impairs the body's ability to maintain a normal core temperature, making the individual susceptible to hypothermia, even in relatively mild environmental conditions. Passive rewarming is preferred because it allows the body to gradually adjust to the increasing temperature, minimizing the risk of sudden vasodilation and hemodynamic instability."
      },
      "opt_3": {
        "point": "Administer a rapid 1-liter bolus of 0.9% sodium chloride.",
        "explanation": "While hypotension is present, rapid fluid boluses are generally avoided in myxedema coma. The hypotension is primarily due to decreased cardiac contractility and bradycardia, not solely hypovolemia. Aggressive fluid administration can precipitate heart failure, especially in elderly clients with underlying cardiac conditions. Furthermore, myxedema coma is often associated with hyponatremia, and rapid fluid boluses can worsen this electrolyte imbalance. Fluid administration should be carefully guided by hemodynamic monitoring and tailored to the client's individual needs. Clinical Pearl: Avoid aggressive fluid resuscitation in myxedema coma due to the risk of heart failure and worsening hyponatremia.",
        "pathophysiology": "The hypotension in myxedema coma is multifactorial, involving decreased cardiac output, reduced systemic vascular resistance, and impaired baroreceptor function. The reduced cardiac output results from decreased myocardial contractility and bradycardia, both direct consequences of thyroid hormone deficiency. The impaired baroreceptor function further contributes to the hypotension by blunting the body's compensatory mechanisms. Hyponatremia, often present in myxedema coma, can exacerbate the hypotension by reducing intravascular volume and impairing cellular function. Rapid fluid boluses can overwhelm the already compromised cardiovascular system, leading to pulmonary edema and heart failure."
      },
      "opt_4": {
        "point": "Prepare for endotracheal intubation and mechanical ventilation.",
        "explanation": "Respiratory depression is a critical complication of myxedema coma. The client's unresponsiveness, shallow respirations, and hypoxia indicate inadequate ventilation and oxygenation. Endotracheal intubation and mechanical ventilation are necessary to secure the airway, provide adequate oxygenation, and remove carbon dioxide. The decreased respiratory drive is due to central nervous system depression caused by severe hypothyroidism. Monitor arterial blood gases (ABGs) closely to guide ventilator settings. Clinical Pearl: Be prepared for intubation and mechanical ventilation in myxedema coma due to the high risk of respiratory failure.",
        "pathophysiology": "Respiratory depression in myxedema coma results from the direct effects of thyroid hormone deficiency on the central nervous system and respiratory muscles. Thyroid hormones are essential for normal brain function, and their deficiency leads to decreased neuronal activity and impaired respiratory drive. The respiratory muscles also become weakened and less responsive, further contributing to hypoventilation. The resulting hypoxemia and hypercapnia can exacerbate the neurological dysfunction and lead to respiratory arrest. Mechanical ventilation provides essential respiratory support, allowing the body to recover from the acute crisis."
      },
      "opt_5": {
        "point": "Administer a sedative to prevent agitation upon arousal.",
        "explanation": "Sedatives are contraindicated in myxedema coma. The client is already in a state of severe central nervous system depression. Administering sedatives (e.g., benzodiazepines, opioids) would further depress respiratory drive and mental status, worsening the coma and potentially leading to respiratory arrest. The primary goal is to support respiratory and cardiovascular function while addressing the underlying thyroid hormone deficiency. Clinical Pearl: Avoid sedatives in myxedema coma as they can worsen respiratory depression and coma.",
        "pathophysiology": "The central nervous system depression in myxedema coma is a direct consequence of thyroid hormone deficiency. Thyroid hormones are crucial for neuronal development, function, and survival. Their deficiency leads to decreased neuronal activity, impaired neurotransmitter synthesis, and reduced cerebral blood flow. Sedatives further depress neuronal activity, exacerbating the existing neurological dysfunction and increasing the risk of respiratory failure and death."
      },
      "opt_6": {
        "point": "Administer IV hydrocortisone as prescribed.",
        "explanation": "Myxedema coma can be associated with or precipitate adrenal insufficiency (Addisonian crisis). The hypothalamic-pituitary-adrenal (HPA) axis may be suppressed due to chronic hypothyroidism or other underlying conditions. Administering thyroid hormone without concurrent glucocorticoid support in a patient with adrenal insufficiency can be fatal, as thyroid hormone increases the metabolic clearance of cortisol. Therefore, IV corticosteroids (e.g., hydrocortisone) are given until coexisting adrenal failure is ruled out. Monitor blood glucose levels, as corticosteroids can cause hyperglycemia. Clinical Pearl: Always administer corticosteroids empirically in myxedema coma to prevent adrenal crisis.",
        "pathophysiology": "Adrenal insufficiency in myxedema coma can result from several mechanisms, including hypothalamic-pituitary dysfunction, autoimmune destruction of the adrenal glands, or impaired cortisol synthesis. Thyroid hormones play a role in regulating the HPA axis, and their deficiency can disrupt cortisol production. Furthermore, the stress of myxedema coma can overwhelm the adrenal glands, leading to a relative or absolute cortisol deficiency. Administering thyroid hormone without glucocorticoid support can further deplete cortisol levels, precipitating a life-threatening adrenal crisis. Hydrocortisone provides exogenous cortisol, supporting blood pressure, glucose metabolism, and immune function."
      },
      "opt_7": {
        "point": "Administer a beta-blocker to manage cardiovascular strain.",
        "explanation": "Beta-blockers are contraindicated in myxedema coma. The client's bradycardia and hypotension are direct consequences of severe hypothyroidism. A beta-blocker would further decrease heart rate and cardiac contractility, exacerbating the hypotension and potentially leading to complete cardiovascular collapse. The treatment is thyroid hormone replacement, which will gradually correct the heart rate and blood pressure. Clinical Pearl: Avoid beta-blockers in myxedema coma as they can worsen bradycardia and hypotension.",
        "pathophysiology": "The bradycardia and hypotension in myxedema coma result from the direct effects of thyroid hormone deficiency on the cardiovascular system. Thyroid hormones increase the number and sensitivity of beta-adrenergic receptors in the heart, enhancing cardiac contractility and heart rate. Their deficiency leads to decreased beta-adrenergic receptor activity, resulting in bradycardia and reduced cardiac output. Beta-blockers further reduce heart rate and contractility by blocking beta-adrenergic receptors, exacerbating the existing cardiovascular dysfunction and potentially leading to life-threatening complications."
      }
    }
  },
  "references": [
    {
      "source": "Ignatavicius, D. D., Workman, M. L., Rebar, C. R., & Heimgartner, N. M. (2021). Medical-surgical nursing: Concepts for interprofessional collaborative care (10th ed.). Elsevier.",
      "chapter": "Chapter on Endocrine Problems"
    },
    {
      "source": "Lewis, S. L., Bucher, L., Heitkemper, M. M., & Harding, M. M. (2020). Medical-surgical nursing: Assessment and management of clinical problems (11th ed.). Elsevier.",
      "chapter": "Chapter on Endocrine Disorders"
    }
  ],
  "difficulty": 4,
  "clientPop": "Adult",
  "contentArea": "Medical-Surgical",
  "keywords": [
    "myxedema coma",
    "hypothyroidism",
    "levothyroxine",
    "mechanical ventilation",
    "hypothermia",
    "adrenal insufficiency"
  ],
  "sbar": {
    "situation": "68-year-old female with history of hypothyroidism admitted for profound lethargy, now unresponsive. Ran out of levothyroxine 2 weeks ago. Diagnosed with myxedema coma.",
    "background": "Assessment: Unresponsive to verbal stimuli, rectal temp 94.8째F (34.9째C), HR 48/min, RR 10/min and shallow, BP 88/50 mmHg.",
    "assessment": "Myxedema coma confirmed. Severe hypothermia, bradycardia, hypotension, and respiratory depression present. High risk for adrenal insufficiency.",
    "recommendation": "Anticipate and prepare for IV levothyroxine and hydrocortisone administration. Prepare for intubation and mechanical ventilation. Initiate passive rewarming. Monitor vital signs and ABGs closely. Avoid rapid fluid boluses and sedatives."
  },
  "sentinelStatus": "healed_v2026_v8"
}